eTheRNA Immunotherapies

Galileilaan 19
Niel
2845

Show jobs for this employer

About eTheRNA Immunotherapies

eTheRNA immunotherapies' mission is to help patients to overcome certain cancers and infectious diseases by developing novel immunotherapies that target the fundamental role of dendritic cells in the human immune system. eTheRNA’s proprietary mRNA-based TriMix technology boosts dendritic cells leading to a more comprehensive, sustainable and safer enhancement of the patient’s immune system than any other similar approach investigated until now.
YEAR FOUNDED:
January 2013
LEADERSHIP:
Founder and CSO: Kris Thielemans
CEO: Dirk Reyn
CMO: Karl-Josef Kallen
JOBS:
Please click here for eTheRNA job opportunities.
CLINICAL TRIAL:
Please click here for clinical trial information.
FOLLOW ETHERNA:

13 articles with eTheRNA Immunotherapies